---
title: "Shibeikang announced the completion of Series B financing, with listed company CHENGDA PHARMA as the exclusive strategic investor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254716773.md"
description: "Recently, Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd. announced the completion of its Series B financing. This round of financing was exclusively strategically invested by the listed company CHENGDA PHARMA. The funds raised will mainly be used to accelerate the construction of the R&D pipeline, expand the R&D laboratory, and promote the international application process of core products. According to Shibeikang, in its early entrepreneurial stage, it also received investments from industrial investors such as Fosun Pharma and Chuan Chuang Investment, as well as local investment institutions"
datetime: "2025-08-27T02:01:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254716773.md)
  - [en](https://longbridge.com/en/news/254716773.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254716773.md)
---

# Shibeikang announced the completion of Series B financing, with listed company CHENGDA PHARMA as the exclusive strategic investor

Recently, Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd. announced the completion of its Series B financing. This round of financing was exclusively strategically invested by the listed company CHENGDA PHARMA. The funds raised will mainly be used to accelerate the construction of the R&D pipeline, expand the R&D laboratory, and promote the international application process of core products. According to Shibeikang, it previously received investments from industrial investors such as Fosun Pharma and Chuan Chuang Investment, as well as local investment institutions during its early startup phase

### Related Stocks

- [301201.CN](https://longbridge.com/en/quote/301201.CN.md)

## Related News & Research

- [Ontada Integrates Florida Cancer Specialists & Research Institute Data to Enrich Its Data Ecosystem](https://longbridge.com/en/news/287218916.md)
- [NEWLY FORMED MANHATTAN URANIUM RECEIVES APPROVAL TO DRILL AT NEVADA'S LARGEST PAST PRODUCING MINE](https://longbridge.com/en/news/287233635.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [Cattle Slipping Lower on Monday](https://longbridge.com/en/news/286885400.md)
- [<![CDATA[Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs]]>](https://longbridge.com/en/news/286948461.md)